Alexander J Denner's Net Worth

$237 Million

Estimate Recalculated May 3, 2024 07:02PM EST

Who is Alexander J Denner?

Alexander J Denner has an estimated net worth of $237 Million. This is based on reported shares across multiple companies, which include BIOGEN INC., IRONWOOD PHARMACEUTICALS INC, Sarissa Capital Acquisition Corp., ENZON PHARMACEUTICALS INC, Iterum Therapeutics plc, ADVENTRX PHARMACEUTICALS INC, APRICUS BIOSCIENCES, INC., Regulus Therapeutics Inc., Bioverativ Inc., Innoviva, Inc., ARIAD PHARMACEUTICALS INC, AMYLIN PHARMACEUTICALS INC, VIVUS INC, MEDICINES CO /DE, and IMCLONE SYSTEMS INC.

SEC CIK

Alexander J Denner's CIK is 0001361754

Past Insider Trading and Trends

2017 was Alexander J Denner's most active year for acquiring shares with 23 total transactions. Alexander J Denner's most active month to acquire stocks was the month of April. 2013 was Alexander J Denner's most active year for disposing of shares, totalling 13 transactions. Alexander J Denner's most active month to dispose stocks was the month of April. 2015 saw Alexander J Denner paying a total of $86,176,250.00 for 408,360 shares, this is the most they've acquired in one year. In 2021 Alexander J Denner cashed out on 35,619,949 shares for a total of $50,007,284.23, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

BIOGEN INC. (BIIB) Snapshot price: $245.55

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+9.98%
1.37K
—
—
15.1K
Jun 15
Form 4
+5.98%
775
—
—
13.73K
Jul 1
Form 4
+7.38%
890
—
—
12.95K
Jun 3
Form 4
+10.59%
1.16K
—
—
12.06K
Jun 19
Form 4
+22.56%
118.34K
$229.94
$27,211,823.50
643K
Apr 30 - May 2
Form 4
+13.60%
62.8K
$327.59
$20,572,406.38
524.66K
Jan 30 - Feb 1
Form 4
+8.77%
880
—
—
10.91K
Jun 12
Form 4
+11.60%
48K
$269.91
$12,955,680.00
461.86K
Apr 25
Form 4
+7.82%
30K
$317.36
$9,520,800.00
413.86K
Nov 28 - Nov 29
Form 4
+0.24%
933
$316.56
$295,350.48
383.86K
Aug 31
Form 4
+11.76%
1.05K
—
—
10.03K
Jun 7
Form 4
+23.83%
73.86K
$278.50
$20,569,475.84
383.86K
Apr 27
Form 4
+13.43%
1.06K
—
—
8.95K
Jun 8
Form 4
∞
310K
$277.47
$86,015,000.00
310K
Oct 22 - Oct 23
Form 4
+9.66%
695
—
—
7.89K
Jun 10
Form 4
+13.75%
870
—
—
7.2K
Jun 12
Form 4
-31.44%
-2.90K
$212.00
-$614,800.00
6.33K
Scheduled
Jun 14
Form 4
+16.48%
1.3K
—
—
9.22K
Jun 12
Form 4
+60.98%
3K
$53.43
$160,290.00
7.92K
Scheduled
May 29
Form 4
—
0
$147.00
-$7,106,693.10
4.92K
Scheduled
May 28
Form 4
-61.86%
-7.98K
$148.62
-$1,185,999.93
4.92K
Scheduled
Dec 26 - Dec 27
Form 4
+18.57%
2.02K
—
—
12.9K
Jun 8
Form 4
+36.71%
2.9K
—
—
10.8K
Jun 1
Form 4
+255.46%
5.74K
—
—
7.98K
Jun 9
Form 4
∞
2.25K
—
—
2.25K
Jun 10
Form 3
—
0
—
—
0
No matching records found

IRONWOOD PHARMACEUTICALS INC (IRWD) Snapshot price: $14.87

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+1.38%
1.66K
—
—
121.94K
Mar 15
Form 4
+1.13%
1.35K
—
—
120.28K
Dec 15
Form 4
+1.54%
1.8K
—
—
118.93K
Sep 15
Form 4
+23.58%
22.35K
—
—
117.13K
Jun 20
Form 4
+1.45%
1.36K
—
—
94.78K
Jun 15
Form 4
+1.56%
1.44K
—
—
93.42K
Mar 15
Form 4
+1.37%
1.24K
—
—
91.98K
Dec 15
Form 4
+1.54%
1.37K
—
—
90.74K
Sep 15
Form 4
+1.39%
1.22K
—
—
89.37K
Jun 15
Form 4
+32.40%
21.57K
—
—
88.14K
Jun 1
Form 4
+1.76%
1.15K
—
—
66.57K
Mar 15
Form 4
+1.89%
1.21K
—
—
65.42K
Dec 15
Form 4
+1.80%
1.14K
—
—
64.21K
Sep 15
Form 4
+1.99%
1.23K
—
—
63.07K
Jun 15
Form 4
+58.26%
22.77K
—
—
61.84K
Jun 2
Form 4
+3.26%
1.24K
—
—
39.08K
Mar 15
Form 4
+1.39%
225K
$10.38
$2,335,500.00
16.39M
Mar 8 - Mar 10
Form 4
+5.04%
775K
$10.01
$7,758,750.00
16.16M
Mar 3 - Mar 5
Form 4
+9.62%
1.35M
$9.44
$12,737,960.00
15.39M
Feb 26 - Mar 2
Form 4
+1.78%
661
—
—
37.84K
Dec 15
Form 4
∞
37.18K
—
—
37.18K
Nov 9
Form 3
—
0
—
—
0
No matching records found

Sarissa Capital Acquisition Corp. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Oct 30
Form 4
—
0
—
—
0
Oct 23
Form 3
—
0
—
—
0
No matching records found

ENZON PHARMACEUTICALS INC (ENZN) Snapshot price: $0.1

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jan 2
Form 4
+54.32%
21.34K
—
—
60.62K
Jul 2
Form 4
—
0
—
—
0
Jan 3
Form 4
+60.22%
14.76K
—
—
39.28K
Jul 1
Form 4
—
0
—
—
0
Jan 3
Form 4
+135.03%
14.09K
—
—
24.52K
Jul 1
Form 4
—
0
—
—
0
Jan 4
Form 4
∞
10.43K
—
—
10.43K
May 21
Form 3
—
0
—
—
0
No matching records found

Iterum Therapeutics plc (ITRM) Snapshot price: $1.7283

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
$2.43
-$50,007,284.23
20.62M
Feb 11 - Feb 12
Form 3
—
0
—
—
0
No matching records found